Search

everythinglearnresearchcommunity

for

Search:↓

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

Botulinum toxin affects hair follicles, inhibiting TGF-B1 secretion; more research ongoing.

A blood pressure drug, diltiazem, may also help treat influenza.

HIF-1A may aid hair growth, Backhousia citriodora improves skin, autologous cells stabilize hair loss, infrared thermography assesses alopecia, and a new treatment preserves hair.

The 0.05% dutasteride topical solution effectively promotes hair growth with fewer side effects than oral treatments.

Injections improve hair growth, density, and thickness in women safely.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Six genetic conditions are often linked to complete scalp hair loss in children.

Photothermal conditioning of PRP shows promise for improving hair growth but needs more research for confirmation.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

New male contraceptive pills show promise in reducing sperm production with mild side effects.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Topical JAK inhibitors may help treat some skin conditions but need more research.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

CG2001 is safe and well-tolerated for treating hair loss in men.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.